IPSC 8-K 2026-10-02

Century Therapeutics, Inc. (IPSC) 8-K dated 2026-10-02 — accession 0001104659-26-113055. This URL is the filing, not the IPSC hub.

Century Therapeutics, Inc. (IPSC) is a biotechnology company listed on US.

Century Therapeutics, Inc. filed a 8-K on 2026-10-02. Accession 0001104659-26-113055.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported IPSC revenue for 2025-12-31 was $109.2M. Net income was -$9.6M. Revenue was up 1556.8% from 2024-12-31 to 2025-12-31. IPSC currently screens at market cap $47.8M.

Not investment advice. The IPSC SEC hub lists recent forms. The stock page is the research view.